3,518
Views
22
CrossRef citations to date
0
Altmetric
Research Article

An efficient enzyme-triggered controlled release system for colon-targeted oral delivery to combat dextran sodium sulfate (DSS)-induced colitis in mice

, , , , , & show all
Pages 1120-1131 | Received 08 Apr 2021, Accepted 18 May 2021, Published online: 12 Jun 2021

References

  • Ahlawat S, Kumar P, Mohan H, et al. (2021). Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium. Crit Rev Microbiol 47:254–73.
  • Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. (2007). Bioavailability of curcumin: problems and promises. Mol Pharm 4:807–18.
  • Arévalo-Pérez R, Maderuelo C, Lanao JM. (2020). Recent advances in colon drug delivery systems. J Control Release 327:703–24.
  • Azevedo MA, Bourbon AI, Vicente AA, Cerqueira MA. (2014). Alginate/chitosan nanoparticles for encapsulation and controlled release of vitamin B2. Int J Biol Macromol 71:141–6.
  • Bansal V, Malviya R, Malaviya T, Sharma PK. (2014). Novel prospective in colon specific drug delivery system. Polim Med 44:109–18.
  • Cheng M, Ma D, Zhi K, et al. (2018). Synthesis of biotin-modified galactosylated chitosan nanoparticles and their characteristics in vitro and in vivo. Cell Physiol Biochem 50:569–84.
  • Dasgupta Y, Golovine K, Nieborowska-Skorska M, et al. (2018). Drugging DNA repair to target T-ALL cells. Leuk Lymphoma 59:1746–9.
  • Descalzo AB, Martínez-Máñez R, Sancenón F, et al. (2006). The supramolecular chemistry of organic-inorganic hybrid materials. Angew Chem Int Ed Engl 45:5924–48.
  • Dhital S, Warren FJ, Butterworth PJ, et al. (2017). Mechanisms of starch digestion by α-amylase-structural basis for kinetic properties. Crit Rev Food Sci Nutr 57:875–92.
  • Di Meo F, Margarucci S, Galderisi U, et al. (2019). Curcumin, gut microbiota, and neuroprotection. Nutrients 11:2426.
  • Grammatikopoulou MG, Gkiouras K, Theodoridis X, et al. (2018). Oral adjuvant curcumin therapy for attaining clinical remission in ulcerative colitis: a systematic review and meta-analysis of randomized controlled trials. Nutrients 10:1737.
  • Han W, Xie B, Li Y, et al. (2019). Orally deliverable nanotherapeutics for the synergistic treatment of colitis-associated colorectal cancer. Theranostics 9:7458–73.
  • He N, Wang S, Lv Z, et al. (2020). Low molecular weight chitosan oligosaccharides (LMW-COSs) prevent obesity-related metabolic abnormalities in association with the modification of gut microbiota in high-fat diet (HFD)-fed mice. Food Funct 11:9947–59.
  • Kobayashi T, Siegmund B, Le Berre C, et al. (2020). Ulcerative colitis. Nat Rev Dis Primers 6:74.
  • Li S, He N, Wang L. (2019). Efficiently anti-obesity effects of unsaturated alginate oligosaccharides (UAOS) in high-fat diet (HFD)-fed mice. Mar Drugs 17:540.
  • Li S, Wang L, Chen X, et al. (2018). Cloning, expression, and biochemical characterization of two new oligoalginate lyases with synergistic degradation capability. Mar Biotechnol (NY) 20:75–86.
  • Li S, Wang L, Jung S, et al. (2020). Biochemical characterization of a new oligoalginate lyase and its biotechnological application in Laminaria japonica degradation. Front Microbiol 11:316.
  • Li S, Wang L, Liu B, He N. (2020). Unsaturated alginate oligosaccharides attenuated obesity-related metabolic abnormalities by modulating gut microbiota in high-fat-diet mice. Food Funct 11:4773–84.
  • Li S, Wang Y, Li X, et al. (2019). Enhancing the thermo-stability and anti-biofilm activity of alginate lyase by immobilization on low molecular weight chitosan nanoparticles. Int J Mol Sci 20:4565.
  • Liu W, Zhai Y, Heng X, et al. (2016). Oral bioavailability of curcumin: problems and advancements. J Drug Target 24:694–702.
  • Maity S, Mukhopadhyay P, Kundu PP, Chakraborti AS. (2017). Alginate coated chitosan core–shell nanoparticles for efficient oral delivery of naringenin in diabetic animals-an in vitro and in vivo approach. Carbohydr Polym 170:124–32.
  • Manju S, Sreenivasan K. (2011). Conjugation of curcumin onto hyaluronic acid enhances its aqueous solubility and stability. J Colloid Interface Sci 359:318–25.
  • Mukhopadhyay P, Chakraborty S, Bhattacharya S, et al. (2015). pH-sensitive chitosan/alginate core–shell nanoparticles for efficient and safe oral insulin delivery. Int J Biol Macromol 72:640–8.
  • Mura S, Nicolas J, Couvreur P. (2013). Stimuli-responsive nanocarriers for drug delivery. Nat Mater 12:991–1003.
  • Nelson KM, Dahlin JL, Bisson J, et al. (2017). The essential medicinal chemistry of curcumin. J Med Chem 60:1620–37.
  • Park C, Kim H, Kim S, Kim C. (2009). Enzyme responsive nanocontainers with cyclodextrin gatekeepers and synergistic effects in release of guests. J Am Chem Soc 131:16614–5.
  • Peng X, Wilken SE, Lankiewicz TS, et al. (2021). Genomic and functional analyses of fungal and bacterial consortia that enable lignocellulose breakdown in goat gut microbiomes. Nat Microbiol 6:499–511.
  • Perše M, Cerar A. (2012). Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol 2012:718617.
  • Pushpamalar J, Sathasivam T, Gugler MC. (2021). Hydrogel beads of natural polymers as a potential vehicle for colon-targeted drug delivery. Methods Mol Biol 2211:171–82.
  • Rivera MC, Pinheiro AC, Bourbon AI, et al. (2015). Hollow chitosan/alginate nanocapsules for bioactive compound delivery. Int J Biol Macromol 79:95–102.
  • Ruiz A, Ma G, Seitsonen J, et al. (2020). Encapsulated doxorubicin crystals influence lysolipid temperature-sensitive liposomes release and therapeutic efficacy in vitro and in vivo. J Control Release 328:665–78.
  • Ruiz-Hernández E, Baeza A, Vallet-Regí M. (2011). Smart drug delivery through DNA/magnetic nanoparticle gates. ACS Nano 5:1259–66.
  • Sacks D, Baxter B, Campbell BCV, et al. (2018). Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke. Int J Stroke 13:612–32.
  • Sadeghi N, Mansoori A, Shayesteh A, Hashemi SJ. (2020). The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis. Phytother Res 34:1123–33.
  • Sadeghi N, Mansoori A, Shayesteh A, Hashemi SJ. (2020). The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis. Phytother Res 34:1123–33.
  • Schroeder A, Goldberg MS, Kastrup C, et al. (2012). Remotely activated protein-producing nanoparticles. Nano Lett 12:2685–9.
  • Shabbir U, Rubab M, Daliri EB, et al. (2021). Curcumin, quercetin, catechins and metabolic diseases: the role of gut microbiota. Nutrients 13:206.
  • Song J, Ma Q, Hu M, et al. (2018). The inhibition of mir-144-3p on cell proliferation and metastasis by targeting TOP2A in HCMV-positive glioblastoma cells. Molecules 23:3259.
  • Sorasitthiyanukarn FN, Muangnoi C, Ratnatilaka Na Bhuket P, et al. (2018). Chitosan/alginate nanoparticles as a promising approach for oral delivery of curcumin diglutaric acid for cancer treatment. Mater Sci Eng C Mater Biol Appl 93:178–90.
  • Tasciotti E. (2018). Smart cancer therapy with DNA origami. Nat Biotechnol 36:234–5.
  • Thai H, Thuy Nguyen C, Thi Thach L, et al. (2020). Characterization of chitosan/alginate/lovastatin nanoparticles and investigation of their toxic effects in vitro and in vivo. Sci Rep 10:909.
  • Tønnesen HH, Karlsen J. (2002). Alginate in drug delivery systems. Drug Dev Ind Pharm 28:621–30.
  • Wang QS, Wang GF, Zhou J, et al. (2016). Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis. Int J Pharm 515:176–85.
  • Xiong MH, Bao Y, Yang XZ, et al. (2012). Lipase-sensitive polymeric triple-layered nanogel for "on-demand" drug delivery. J Am Chem Soc 134:4355–62.
  • Zhang G, Yang M, Cai D, et al. (2014). Composite of functional mesoporous silica and DNA: an enzyme-responsive controlled release drug carrier system. ACS Appl Mater Interfaces 6:8042–7.